Articles On Hydrix (ASX:HYD)

The COVID-19 pandemic left a lot of medical device companies scrambling to keep up with the unprecedented disruption. And when we caught up with Micro-X (ASX:MX1) CEO Peter Rowland earlier this week, he said the main challenge was presented...

A quick wrap of the ASX’s key winners and losers on Wednesday, August 19. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 671 stocks rose, 688 declined an...

A quick wrap of the ASX’s key winners and losers on Tuesday, August 18. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 888 stocks rose, 534 declined and...

B2B data management company 9Spokes (ASX:9SP) is back on the distribution path, this time with a focus on the US market. The company announced a five-year agreement with Fundation — a fintech lender focused on providing debt capital for sma...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Australian company Hydrix (ASX:HYD) has announced the first supply and implant of its AngelMed Guardian device.

A quick wrap of the ASX’s key winners and losers on Monday, August 17. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 658 stocks rose, 689 declined and 7...

The Hydrix Ltd (ASX: HYD) share price blasted off today (and that’s no exaggeration), gaining more than 253% to trade at 31.5 cents just prior to the market’s close. And this on a day when the All Ordinaries Index (ASX: XAO) is down 0.8%....

Cardiovascular technology promoter Hydrix (ASX: HYD) has confirmed its AngelMed Guardian implantable heart attack alerting device has been used for the first time in four separate surgical procedures at a Singapore hospital. The surgeries w...

The medtech division of diversified engineering firm Hydrix (ASX:HYD) has implanted its AngelMed Guardian heart-monitoring system in four patients in Singapore. As the exclusive distributor of the US-made technology into the Asia-Pacific, H...

ASX companies continued to raise money in July, with over $4bn shelled out by investors, taking 2020’s total above $30bn. According to Bloomberg, there has been $32.3bn worth of cash raised between January 1 and August 3. This is well ahead...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Last week in our discussion with Bourse Communication founder and Managing Director Rod North, we examined how COVID-19 compared to other great market impacting events such as the 1987 crash the recession we had to have. This week, we look...

A quick wrap of the key winners and losers on Thursday, April 30. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. WINNERS CODE COMPANY PR...

Special Report: Wright says his skillset is ideally suited to add value as the company embarks on an exciting growth phase. For Hydrix (ASX:HYD), FY20 is shaping up as a defining year for the business as it looks to continue earnings moment...

Special Report: The Victoria-based engineering firm has built up an impressive client base of multinational customers, with plenty of upside ahead after doubling annual revenues. Advanced engineering firm Hydrix (ASX:HYD) is beginning to se...

Each fortnight, Stockhead checks who’s leading the tech sector and this time we’ve found a music tech stock leading the charge. Jaxsta (ASX:JXT) is up 59 per cent this fortnight. This company says it’s on a mission to create the world’s mos...

It is not often that headlines on the ASX really stand out. Aside from the obvious mining hits, tech partnerships and biotech results, most of the announcements released via the ASX’s platform each day read “daily share buyback notice”, “ap...

Medical tech stock AdAlta (ASX:1AD) thinks that when it comes to immunisation, what works for sharks can also work for humans. And the company’s technology has caught the eye of global player GE Healthcare. AdAlta announced this morning tha...

Technology is the use of scientific knowledge for practical purposes, and it forms an important aspect of economic development. There are other factors as well that influence economic development; however, technology is one of the major sec...

Medibio (ASX: MEB) has gained 24 per cent this morning after announcing an integration partnership with digital corporate wellness solution WellteQ. Medibio’s “ilumen” digital mental well-being assessment will be integrated into WellteQ’s s...

It’s quarterlies season for ASX investors today, and listed small caps are out in force with their trading updates for the June quarter. For some there’s not much market reaction, but there’s always a few 4C filings that draw a response. W...

S&P/ASX 200, the benchmark index, is trading at A$6,653.2 on 03 July 2019 (AEST 01:24 PM), marginally up by 0.46% from its previous close, with S&P/ASX 200 Consumer Staples (Sector) leading the pack with an upsurge of 1.84%. In this...

Hydrix (ASX:HYD) is forecasting “record” revenue of $4.3m in the June quarter and its first ever profit of sorts. This quarter the company expects to deliver a maiden cash operating profit of around $400,000 and full year revenue around $13...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...